Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies

IntroductionComplex in vitro respiratory models, including air-liquid interface (ALI) transwell cultures and airway organoids, have emerged as promising tools for studying human respiratory virus infections. These models address several limitations of conventional two-dimensional cell line and anim...

Full description

Saved in:
Bibliographic Details
Main Authors: Camilla T. Ekanger, Nilima Dinesh Kumar, Rosanne W. Koutstaal, Fan Zhou, Martin Beukema, Joanna Waldock, Simon P. Jochems, Noa Mulder, Cécile A. C. M. van Els, Othmar G. Engelhardt, Nathalie Mantel, Kevin P. Buno, Karl Albert Brokstad, Agnete S. T. Engelsen, Rebecca J. Cox, Barbro N. Melgert, Anke L. W. Huckriede, Puck B. van Kasteren
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532144/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087120934600704
author Camilla T. Ekanger
Camilla T. Ekanger
Camilla T. Ekanger
Nilima Dinesh Kumar
Rosanne W. Koutstaal
Fan Zhou
Martin Beukema
Joanna Waldock
Simon P. Jochems
Noa Mulder
Cécile A. C. M. van Els
Cécile A. C. M. van Els
Othmar G. Engelhardt
Nathalie Mantel
Kevin P. Buno
Karl Albert Brokstad
Karl Albert Brokstad
Agnete S. T. Engelsen
Agnete S. T. Engelsen
Rebecca J. Cox
Rebecca J. Cox
Barbro N. Melgert
Barbro N. Melgert
Anke L. W. Huckriede
Puck B. van Kasteren
author_facet Camilla T. Ekanger
Camilla T. Ekanger
Camilla T. Ekanger
Nilima Dinesh Kumar
Rosanne W. Koutstaal
Fan Zhou
Martin Beukema
Joanna Waldock
Simon P. Jochems
Noa Mulder
Cécile A. C. M. van Els
Cécile A. C. M. van Els
Othmar G. Engelhardt
Nathalie Mantel
Kevin P. Buno
Karl Albert Brokstad
Karl Albert Brokstad
Agnete S. T. Engelsen
Agnete S. T. Engelsen
Rebecca J. Cox
Rebecca J. Cox
Barbro N. Melgert
Barbro N. Melgert
Anke L. W. Huckriede
Puck B. van Kasteren
author_sort Camilla T. Ekanger
collection DOAJ
description IntroductionComplex in vitro respiratory models, including air-liquid interface (ALI) transwell cultures and airway organoids, have emerged as promising tools for studying human respiratory virus infections. These models address several limitations of conventional two-dimensional cell line and animal models. However, the lack of standardized protocols for the application of these models in infection studies limits the possibilities for comparing results across different research groups. Therefore, we applied a collaborative approach to harmonize several aspects of experimental methodology between different research laboratories, aiming to assess the comparability of different models of human airway epithelium in the context of respiratory viral infections.MethodsIn this study, we compared three different models of human respiratory epithelium: a primary human bronchial epithelial cell-derived ALI transwell model, and two airway organoid models established from human airway- and lung-derived adult stem cells. We first assessed the presence of various differentiated cell types using immunofluorescence microscopy. Using a shared stock of influenza A virus, we then assessed viral growth kinetics, epithelial cytokine responses, and serum-mediated inhibition of infection.ResultsThe presence of club, goblet, and ciliated cells was confirmed in all models. We observed similar viral replication kinetics with a >4-log increase in virus titre across all models using a TCID50 assay. Following infection, a reproducible antiviral cytokine response, including a consistent increase in CXCL10, IL-6, IFN-λ1, IFN-λ2/3, and IFN-β, was detected across all models. Finally, neutralization was assessed by pre-incubation of virus with human serum. Reduced viral replication was observed across all models, resulting in a 3- to 6-log decrease in virus titres as quantified by TCID50.DiscussionIn conclusion, all three models produced consistent results regardless of the varying cell sources, culturing approaches, and infection methods. Our collaborative efforts to harmonize infection experiments and compare ALI transwell and airway organoid models described here aid in advancing our understanding and improving the standardization of these complex in vitro respiratory models for future studies.
format Article
id doaj-art-58f22a426f6a48649e6b3149113b6e98
institution Kabale University
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-58f22a426f6a48649e6b3149113b6e982025-02-06T07:10:09ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15321441532144Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studiesCamilla T. Ekanger0Camilla T. Ekanger1Camilla T. Ekanger2Nilima Dinesh Kumar3Rosanne W. Koutstaal4Fan Zhou5Martin Beukema6Joanna Waldock7Simon P. Jochems8Noa Mulder9Cécile A. C. M. van Els10Cécile A. C. M. van Els11Othmar G. Engelhardt12Nathalie Mantel13Kevin P. Buno14Karl Albert Brokstad15Karl Albert Brokstad16Agnete S. T. Engelsen17Agnete S. T. Engelsen18Rebecca J. Cox19Rebecca J. Cox20Barbro N. Melgert21Barbro N. Melgert22Anke L. W. Huckriede23Puck B. van Kasteren24Department of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, NorwayCentre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Bergen, NorwayInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, NorwayDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsInfluenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, United KingdomLeiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, NetherlandsGroningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, NetherlandsCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsSection Immunology, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, NetherlandsInfluenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, United Kingdom0Sanofi, Marcy L’Etoile, France1GlaxoSmithKline (GSK), Siena, ItalyInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway2Department of Safety, Chemistry and Biomedical Laboratory Sciences, Western Norway University of Applied Sciences, Bergen, NorwayDepartment of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, NorwayCentre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Bergen, NorwayInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway3Department of Microbiology, Haukeland University Hospital, Bergen, NorwayGroningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands4Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, NetherlandsIntroductionComplex in vitro respiratory models, including air-liquid interface (ALI) transwell cultures and airway organoids, have emerged as promising tools for studying human respiratory virus infections. These models address several limitations of conventional two-dimensional cell line and animal models. However, the lack of standardized protocols for the application of these models in infection studies limits the possibilities for comparing results across different research groups. Therefore, we applied a collaborative approach to harmonize several aspects of experimental methodology between different research laboratories, aiming to assess the comparability of different models of human airway epithelium in the context of respiratory viral infections.MethodsIn this study, we compared three different models of human respiratory epithelium: a primary human bronchial epithelial cell-derived ALI transwell model, and two airway organoid models established from human airway- and lung-derived adult stem cells. We first assessed the presence of various differentiated cell types using immunofluorescence microscopy. Using a shared stock of influenza A virus, we then assessed viral growth kinetics, epithelial cytokine responses, and serum-mediated inhibition of infection.ResultsThe presence of club, goblet, and ciliated cells was confirmed in all models. We observed similar viral replication kinetics with a >4-log increase in virus titre across all models using a TCID50 assay. Following infection, a reproducible antiviral cytokine response, including a consistent increase in CXCL10, IL-6, IFN-λ1, IFN-λ2/3, and IFN-β, was detected across all models. Finally, neutralization was assessed by pre-incubation of virus with human serum. Reduced viral replication was observed across all models, resulting in a 3- to 6-log decrease in virus titres as quantified by TCID50.DiscussionIn conclusion, all three models produced consistent results regardless of the varying cell sources, culturing approaches, and infection methods. Our collaborative efforts to harmonize infection experiments and compare ALI transwell and airway organoid models described here aid in advancing our understanding and improving the standardization of these complex in vitro respiratory models for future studies.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532144/fullinfluenza virusmucosal modelsrespiratory tractcomplex in vitro modelsharmonization
spellingShingle Camilla T. Ekanger
Camilla T. Ekanger
Camilla T. Ekanger
Nilima Dinesh Kumar
Rosanne W. Koutstaal
Fan Zhou
Martin Beukema
Joanna Waldock
Simon P. Jochems
Noa Mulder
Cécile A. C. M. van Els
Cécile A. C. M. van Els
Othmar G. Engelhardt
Nathalie Mantel
Kevin P. Buno
Karl Albert Brokstad
Karl Albert Brokstad
Agnete S. T. Engelsen
Agnete S. T. Engelsen
Rebecca J. Cox
Rebecca J. Cox
Barbro N. Melgert
Barbro N. Melgert
Anke L. W. Huckriede
Puck B. van Kasteren
Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
Frontiers in Immunology
influenza virus
mucosal models
respiratory tract
complex in vitro models
harmonization
title Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
title_full Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
title_fullStr Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
title_full_unstemmed Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
title_short Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
title_sort comparison of air liquid interface transwell and airway organoid models for human respiratory virus infection studies
topic influenza virus
mucosal models
respiratory tract
complex in vitro models
harmonization
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532144/full
work_keys_str_mv AT camillatekanger comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT camillatekanger comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT camillatekanger comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT nilimadineshkumar comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT rosannewkoutstaal comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT fanzhou comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT martinbeukema comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT joannawaldock comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT simonpjochems comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT noamulder comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT cecileacmvanels comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT cecileacmvanels comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT othmargengelhardt comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT nathaliemantel comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT kevinpbuno comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT karlalbertbrokstad comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT karlalbertbrokstad comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT agnetestengelsen comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT agnetestengelsen comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT rebeccajcox comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT rebeccajcox comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT barbronmelgert comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT barbronmelgert comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT ankelwhuckriede comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies
AT puckbvankasteren comparisonofairliquidinterfacetranswellandairwayorganoidmodelsforhumanrespiratoryvirusinfectionstudies